Heart Disease Trial, Recruiting NCT07649330 Sponsor: Siou-Pin Huang Condition: Heart Disease
Back to Heart Disease

Heart Disease Trial, Recruiting

NCT07649330
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults aged 18 or older
  • People who are able to speak and follow instructions
  • People who have been diagnosed by a doctor with a heart artery condition, a heart valve condition, or a disease affecting the large blood vessel leaving the heart (the aorta)
  • People who are scheduled to have a type of chest surgery that involves cutting through the breastbone (called a median sternotomy)
  • People who are able to give their written agreement to take part in the trial

Who may not be able to join:

  • People who have a cardiac pacemaker (a small device implanted to help control heartbeat)
  • People who have a ventricular assist device, which is a mechanical pump used to support heart function
  • People who have a condition affecting the brain or spinal cord, such as a history of stroke, spinal cord injury, or traumatic brain injury
  • People who have difficulty with memory, thinking, or understanding instructions
  • People who have been diagnosed with chronic obstructive pulmonary disease (COPD), a long-term lung condition that makes breathing difficult
  • People who have had previous surgery on the chest area
  • People whose stay in the intensive care unit (ICU) lasted longer than 14 days

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 19 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +886 988 366 335

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Siou-Pin Huang
Registry
ClinicalTrials.gov
Start date
25 March 2026
Est. completion
1 May 2027

Where this trial is recruiting

🇹🇼 Taiwan

Primary endpoints

Maximum inspiratory pressure (MIP) and maximum expiratory pressure (MEP)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov